Higher Medicine (HMd) and its Delaware subsidiary, HigherTherapeutics (HTx), announced it has been awarded a grant in the Spring 2025 EDGE competition by the Delaware Division of Small Business.
The EDGE (Encouraging Development, Growth and Expansion) Grant is a competitive program that supports early-stage Delaware businesses poised for scalable impact. Each round, five STEM-based companies are selected to receive up to $100,000 in funding. HMd/HTx was one of just five STEM awardees chosen statewide.
The EDGE funding will support IND-enabling regulatory research as well as early team building. The investment will help advance lead compound validation, strengthen internal capabilities, and prepare the company for future partnerships and clinical execution.
“I am incredibly excited by the diverse range of small businesses that we were able to support during this round of the EDGE competition,” said CJ Bell, Director of the Delaware Division of Small Business. “These companies are contributing to the quality of life of Delawareans in a variety of ways. I’m proud that through this funding, we are able to help elevate them to the next level.”
The award was the result of a competitive review and live pitch process, in which finalists were selected from a pool of 139 applicants across STEM and non-STEM categories.
To learn more about the EDGE Grant and view the full list of Spring 2025 recipients, visit:
